Sucralfate tablets

Sucralfate tablets
Product Description

sucralfate, sold under various brand names, is a medication used to treat stomach ulcers, gastroesophageal reflux disease, radiation proctitis, and stomach inflammation and to prevent stress ulcers. Its usefulness in people infected by H. pylori is limited.

Read more Show less

Lyrus Life Sciences

  • IN
  • 2019
    On CPHI since
  • 4
    Certificates
  • 250 - 499
    Employees
Company types
Contract Research Organisation (CRO)
Generics/Biosimilars Manufacturer
Primary activities
Pharmaceutical Company (generic finished products)
View company profile
Categories
more categories Show less
Specifications
  • Supplied from
    India
More specifications Fewer specifications
Sales Markets
Show more Show less

Lyrus Life Sciences

  • IN
  • 2019
    On CPHI since
  • 4
    Certificates
  • 250 - 499
    Employees
Company types
Contract Research Organisation (CRO)
Generics/Biosimilars Manufacturer
Primary activities
Pharmaceutical Company (generic finished products)
View company profile

More Products from Lyrus Life Sciences (3)

  • Methenamine Hippurate Tabs 1000 mg

    Product Methenamine Hippurate Tabs 1000 mg

    METHENAMINE is used to prevent urinary tract infections due to bacteria. It is not used to treat an active infection. It will not work for colds, flu, or other viral infections.
  • Metformin PR tablets

    Product Metformin PR tablets

    Metformin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. It is used in patients with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems.
  • Nitrofurantoin Capsules

    Product Nitrofurantoin Capsules

    Nitrofurantoin is used to treat urinary tract infections. This medicine is an antibiotic. It works by killing bacteria or preventing their growth.

Lyrus Life Sciences resources (2)

  • Lyrus Receives US FDA approval for Critical UTI treatment in the US

    News Lyrus Receives US FDA approval for Critical UTI treatment in the US

    Lyrus has received US FDA approval for our Abbreviated New Drug Application (ANDA) for 'Methenamine Hippurate Tablets USP, 1 gram', an AB-rated, substitutable generic version of Hiprex®. 
     
    18 Dec 2023
  • Lyrus Life Science Brochure

    Brochure Lyrus Life Science Brochure

    Introduction:The Lyrus Life Science brochure provides a comprehensive overview of our company's capabilities, management profile, research and development strengths, and production facilities. It serves as a valuable resource to gain insights into our operations and the therapies we specialize in. At Lyrus Life Science, we are committed to developing innovative products using non-infringing technologies, revolutionizing the healthcare industry.